Race, insurance status, and desire for tubal sterilization reversal
Received 18 January 2007; received in revised form 7 June 2007; accepted 7 June 2007. published online 19 September 2007.
Objective
To examine the independent effects of race/ethnicity and insurance status on desire for tubal sterilization reversal.
Design
Secondary analysis of cross-sectional data collected by the 2002 National Survey of Family Growth (NSFG).
Setting
Interviews were conducted in person by a trained female interviewer in the participant's home.
Patient(s)
The NSFG is designed to represent women and men 15–44 years of age in the U.S. household population. The sample consisted of 934 women who had undergone tubal sterilization at any time before being interviewed.
Intervention(s)
None.
Main Outcome Measure(s)
Desire for sterilization reversal.
Result(s)
Among women older than 30 years at time of surgery, black women were significantly more likely to desire sterilization reversal compared with white women (adjusted odds ratio, 2.6; 95% confidence interval, 1.2, 5.8). In the total cohort and in the subset of women 30 years or younger, there were no significant racial/ethnic variations in desire for sterilization reversal.
Conclusion(s)
Among women over age 30 at the time of tubal sterilization, black women were much more likely to express desire for reversal than white women.
aDivision of General Internal Medicine, VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
bDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Women's Research Institute, Pittsburgh, Pennsylvania
cDivision of General Internal Medicine, Center for Research on Health Care, Pittsburgh, Pennsylvania
dInstitute for Clinical Research Education, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
eDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania
fCenter for Health Equity and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
Reprint requests: Said A. Ibrahim, M.D., M.P.H., Associate Professor of Medicine, Center for Health Equity Research and Promotion (151-C), VA Pittsburgh HealthCare System, Pittsburgh, PA 15240 (FAX: 412-688-6527).
Dr. Creinin is a consultant and advisor for Organon; is on the speaker's bureau for Berlex and Organon; and has received research grants from Organon, Galen, and Berlex.
ABSTRACT